Published in Ann Surg Oncol on May 01, 2001
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg (2010) 2.72
Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg (2006) 2.49
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol (2011) 1.63
Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg (2007) 1.52
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol (2009) 1.50
Current treatment for colorectal liver metastases. World J Gastroenterol (2011) 1.38
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. Br J Cancer (2009) 1.25
Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer (2007) 1.16
Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol (2012) 1.15
Response evaluation of chemotherapy in metastatic colorectal cancer by contrast enhanced ultrasound. World J Gastroenterol (2012) 1.15
Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis (2008) 1.11
Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging (2006) 1.10
The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study. Virchows Arch (2007) 1.04
Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol (2010) 1.03
Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann Surg Oncol (2011) 1.01
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC Cancer (2004) 0.99
Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis (2012) 0.97
Future directions for monitoring treatment response in colorectal cancer. J Cancer (2014) 0.96
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report. J Hematol Oncol (2009) 0.94
Radiofrequency Ablation for Colon and Rectal Carcinoma Liver Metastases: What's Missing? Gastrointest Cancer Res (2007) 0.94
Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis (2011) 0.93
Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg (2009) 0.93
Why hasn't the National Institute been 'NICE' to patients with colorectal cancer? National Institute of Clinical Excellence. Br J Cancer (2002) 0.93
Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience. Surg Today (2014) 0.92
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) (2010) 0.90
Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World J Surg (2010) 0.90
Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate? Int J Clin Oncol (2012) 0.89
Prognostic indicator for the resection of liver metastasis of colorectal cancer. Surg Today (2013) 0.89
Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials. BMC Cancer (2010) 0.89
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52. Clin Colorectal Cancer (2011) 0.89
Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg (2006) 0.88
Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg (2004) 0.87
Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review. HPB Surg (2008) 0.87
How to operate a liver tumor you cannot see. Langenbecks Arch Surg (2009) 0.86
Follow-up recommendations for colon cancer. Clin Colon Rectal Surg (2005) 0.85
A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases. BMC Cancer (2009) 0.85
Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial. Br J Cancer (2013) 0.84
Role of cetuximab in first-line treatment of metastatic colorectal cancer. World J Gastroenterol (2014) 0.84
Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases. World J Surg (2012) 0.83
Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg (2013) 0.83
Evolution in the treatment of metastatic colorectal carcinoma of the liver. World J Gastroenterol (2006) 0.83
Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer. World J Surg (2008) 0.83
Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol (2010) 0.83
Multi-modality treatment of colorectal liver metastases. World J Gastroenterol (2012) 0.82
Patients with multiple synchronous colonic cancer hepatic metastases benefit from enrolment in a "liver first" approach protocol. World J Hepatol (2014) 0.82
Patient selection for hepatic resection for metastatic colorectal cancer. J Gastrointest Oncol (2012) 0.82
A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients. Br J Cancer (2003) 0.82
Hepatic resection in Canada: rates and geographic variation. Can J Surg (2009) 0.81
PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging (2008) 0.81
Milestones in the evolution of hepatic surgery. Rambam Maimonides Med J (2011) 0.80
Long-term survival following radiofrequency ablation of colorectal liver metastases: A retrospective study. World J Gastrointest Surg (2015) 0.80
Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases. HPB (Oxford) (2013) 0.80
Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer. Surg Today (2012) 0.80
Current directions in chemotherapy for colorectal cancer. J Gastroenterol (2006) 0.79
Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases. Ann Surg Oncol (2010) 0.79
Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases. HPB (Oxford) (2011) 0.79
Use of chemotherapy and radiofrequency ablation to treat colorectal cancer metastases: a retrospective review of The Ottawa Hospital Cancer Centre over 7 years. Curr Oncol (2014) 0.79
Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy. J Cancer Res Clin Oncol (2007) 0.79
Analysis of treatment that includes both hepatic and pulmonary resections for colorectal metastases. Surg Today (2013) 0.79
Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trial. BMC Cancer (2015) 0.78
Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases. J Gastrointest Oncol (2014) 0.78
Role of surgery in colorectal liver metastases: too early or too late? World J Gastroenterol (2010) 0.78
Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis. World J Surg Oncol (2015) 0.78
Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases. J Transl Med (2011) 0.78
Aggressive liver resection including major-vessel resection for colorectal liver metastases. World J Hepatol (2009) 0.78
Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors. Sci Rep (2017) 0.78
Safety of hepatic resection for colorectal metastases in the era of neo-adjuvant chemotherapy. Langenbecks Arch Surg (2011) 0.77
Surgical options for initially unresectable colorectal liver metastases. HPB Surg (2012) 0.77
Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer. World J Gastroenterol (2010) 0.77
Advances in therapeutics for liver metastasis from colorectal cancer. World J Gastrointest Oncol (2010) 0.77
Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases. Ann Coloproctol (2016) 0.77
FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION. Arq Bras Cir Dig (2015) 0.76
Clinical risk score can be used to select patients for staging laparoscopy and laparoscopic ultrasound for colorectal liver metastases. World J Surg (2010) 0.76
Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity. Ther Adv Med Oncol (2010) 0.75
Colorectal cancer: what the clinician wants to know. Cancer Imaging (2005) 0.75
Resection of colorectal liver metastases following neoadjuvant chemotherapy. Ecancermedicalscience (2007) 0.75
Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. World J Gastroenterol (2016) 0.75
Oxaliplatin but not irinotecan impairs posthepatectomy liver regeneration in a murine model. Int J Hepatol (2011) 0.75
Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases: A propensity score matching analysis. Medicine (Baltimore) (2017) 0.75
Hepatic histopathology and postoperative outcome after preoperative chemotherapy for Chinese patients with colorectal liver metastases. World J Gastrointest Surg (2013) 0.75
Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases. Indian J Surg Oncol (2013) 0.75
Potential Prognostic Impact of Baseline CEA Level and Surgery of Primary Tumor Among Patients with Synchronous Stage IV Colorectal Cancer: A Large Population Based Study. Indian J Surg Oncol (2015) 0.75
Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series. HPB (Oxford) (2012) 0.75
Successful curative resection of gallbladder cancer following S-1 chemotherapy: A case report and review of the literature. Oncol Lett (2014) 0.75
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016. Curr Oncol (2016) 0.75
Rebound growth of hepatic colorectal metastases after neo-adjuvant chemotherapy: effect on survival after resection. HPB (Oxford) (2016) 0.75
Novel methods for clinical risk stratification in patients with colorectal liver metastases. Cancer Res Treat (2014) 0.75
Stereotactic excision of additional lesions detected with intraoperative ultrasound examination during radiofrequency dissecting sealar (habib®) assisted hepatic metastasectomy: report of 4 cases. Indian J Surg (2012) 0.75
Assessment of Tumor Response and Resection Rates in Unresectable Colorectal Liver Metastases Following Neoadjuvant Chemotherapy with Cetuximab. Indian J Surg Oncol (2015) 0.75
Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study. Int J Clin Oncol (2012) 0.75
Influence of preoperative chemotherapy on CT volumetric liver regeneration following right hemihepatectomy. World J Surg (2014) 0.75
Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy. World J Surg (2016) 0.75
[New aspects for staging and grading of tumor metastases]. Pathologe (2015) 0.75
The European mesothelioma epidemic. Br J Cancer (1999) 6.28
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg (1996) 4.41
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol (1999) 2.80
Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg (1992) 2.76
European cancer mortality predictions for the year 2013. Ann Oncol (2013) 2.71
Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. Am J Transplant (2015) 2.71
The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol (1990) 2.62
Epidemiology of biliary tract cancers: an update. Ann Oncol (2008) 2.51
Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol (2001) 2.43
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32
Major hepatic resection under total vascular exclusion. Ann Surg (1989) 2.29
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28
Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg (1988) 2.26
Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol (2009) 2.20
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg (2000) 2.16
Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol (2013) 2.09
A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control (1999) 2.08
Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg (2003) 2.04
Worldwide trends in suicide mortality, 1955-1989. Acta Psychiatr Scand (1994) 2.01
Repeat hepatectomy for colorectal liver metastases. Ann Surg (1997) 1.99
Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant (2010) 1.93
Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol (2008) 1.91
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86
Western and eastern European trends in testicular cancer mortality. Lancet (2001) 1.80
Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol (2013) 1.79
Repeat hepatectomy for recurrent colorectal metastases. Br J Surg (2013) 1.77
Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg (2010) 1.73
Lung cancer mortality in European women: recent trends and perspectives. Ann Oncol (2005) 1.73
Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg (2010) 1.72
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol (2009) 1.71
A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control (2000) 1.70
Short- and long-term donor morbidity in right lobe living donor liver transplantation: 91 consecutive cases in a European Center. Am J Transplant (2011) 1.70
Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68
Laparoscopic liver resection of benign liver tumors. Surg Endosc (2002) 1.68
Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet (1992) 1.68
Trends of cancer mortality in Europe, 1955-1989: II, Respiratory tract, bone, connective and soft tissue sarcomas, and skin. Eur J Cancer (1992) 1.66
Major and minor segmentectomies "réglées" in liver surgery. World J Surg (1982) 1.65
The use of operative ultrasound in surgery of primary liver tumors. World J Surg (1987) 1.64
Vascular reconstruction combined with liver resection for malignant tumours. Br J Surg (2013) 1.63
Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology (1983) 1.62
Trends in mortality from major diseases in Europe, 1980-1993. Eur J Epidemiol (1998) 1.59
Cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and in nondrinkers who smoke tobacco. J Natl Cancer Inst (1998) 1.58
Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol (2005) 1.57
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
Epidemiology and prevention of oral cancer. Oral Oncol (1997) 1.53
European cancer mortality predictions for the year 2012. Ann Oncol (2012) 1.52
Sex differences in colorectal cancer mortality in Europe, 1955-1996. Eur J Cancer Prev (2000) 1.52
A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control (1999) 1.50
Nonmelanomatous skin cancer following cervical, vaginal, and vulvar neoplasms: etiologic association. J Natl Cancer Inst (1998) 1.45
A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control (1999) 1.45
Trends in brain cancer. Lancet (1989) 1.45
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45
Chronopharmacological study of antihistamines in man with special references to terfenadine. Eur J Clin Pharmacol (1978) 1.43
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41
Long-term outcome in patients with adrenal metastases following resection of colorectal liver metastases. Br J Surg (2009) 1.41
Living related hepatic donation: Prometheus or Pandora's box? Aust N Z J Surg (1993) 1.38
Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38
[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]. Gastroenterol Clin Biol (2001) 1.38
Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control (2002) 1.38
Emergency orthotopic liver transplantation in two patients using one donor liver. Br J Surg (1989) 1.38
European cancer mortality predictions for the year 2011. Ann Oncol (2011) 1.35
Split-liver transplantation. The Paul Brousse policy. Ann Surg (1996) 1.35
Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer (1998) 1.31
Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol (2011) 1.29
Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg (1995) 1.29
Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart (2006) 1.29
Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg (1997) 1.29
Trends of cancer mortality in Europe, 1955-1989: I, Digestive sites. Eur J Cancer (1992) 1.26
A genetic map of melon highly enriched with fruit quality QTLs and EST markers, including sugar and carotenoid metabolism genes. Theor Appl Genet (2010) 1.24
Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet (1989) 1.23
Diverging trends in breast cancer mortality within Switzerland. Ann Oncol (2005) 1.22
Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses. Ann Oncol (2001) 1.22
Site distribution of different types of skin cancer: new aetiological clues. Int J Cancer (1996) 1.21
Red meat intake and cancer risk: a study in Italy. Int J Cancer (2000) 1.21
Microsatellite instability in European hepatocellular carcinoma. Oncogene (1999) 1.19
Diaphragm dysfunction induced by upper abdominal surgery. Role of postoperative pain. Am Rev Respir Dis (1983) 1.19
Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation (2006) 1.19
Epidemiology of unknown primary tumours. Eur J Cancer (2002) 1.18
Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab (1990) 1.18
Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg (1995) 1.17
Leanness as early marker of cancer of the oral cavity and pharynx. Ann Oncol (2001) 1.17
Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma. Histopathology (2001) 1.16
Circadian changes in the pharmacokinetics of oral ketoprofen. Clin Pharmacokinet (1987) 1.15
The outcome of steatotic grafts in liver transplantation. Transplant Proc (1991) 1.15